| 银杏二萜内酯葡胺注射液通过调控炎症和凋亡信号通路减轻OGD/R诱导的细胞损伤（英文） |
| |
| 引用本文： | 洪倩,王增慧,杨阳,高璐,闫兆. 银杏二萜内酯葡胺注射液通过调控炎症和凋亡信号通路减轻OGD/R诱导的细胞损伤（英文）[J]. 中国药学, 2020, 29(7): 455-469. DOI: 10.5246/jcps.2020.07.043 |
| |
| 作者姓名： | 洪倩 王增慧 杨阳 高璐 闫兆 |
| |
| 作者单位： | 中国人民解放军第71部队医院徐州医科大学附属淮海医院 |
| |
| 摘 要： | 银杏二萜内酯葡胺注射液(DGMI)是一种银杏叶提取物注射液,目前用于缺血性中风恢复期的治疗。在本研究中,我们旨在证实DGMI是否可以抑制炎症反应和细胞凋亡,并探讨这些作用的潜在机制。将细胞暴露于氧-糖剥夺/复氧(OGD/R)后,通过MTS和LDH测定法测量细胞活力和乳酸脱氢酶(LDH)释放量。使用AnnexinV-FITC/PI双重染色分析试剂盒通过流式细胞仪检测了DGMI的抗凋亡作用。通过特定的Bio-PlexProTM剂盒对包括TNF-α、IL-1β、IL-6和IL-10在内的促炎性细胞因子进行定量检测。此外,分别通过蛋白质印迹分析和免疫荧光染色测定TLR2/4,NF-κBp65,MAPK通路激活和凋亡相关蛋白的活性以及NF-κBp65的细胞定位。结果显示,50μg/mL的DGMI在OGD/R诱导的BV2小胶质细胞中显著提高了细胞活力并降低了IL-1β,IL-6,IL-10和TNF-α的分泌。通过LDH测定和AnnexinV-FITC/PI染色也证实了这些作用。同时,DGMI不仅抑制TLR2,TLR4,MyD88,p-TAK1,p-Ik Bk,p-IKKK和B...
|
| 关 键 词： | 银杏内酯 BV2神经小胶质细胞 TLR 脑缺血 NF-κB MAPK 炎症 |
| 收稿时间： | 2020-03-16 |
DGMI alleviates OGD/R-induced cell injury by regulating inflammatory and apoptosis signaling pathways |
| |
| Qian Hong,Zenghui Wang,Yang Yang,Lu Gao,Zhao Yan. DGMI alleviates OGD/R-induced cell injury by regulating inflammatory and apoptosis signaling pathways[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(7): 455-469. DOI: 10.5246/jcps.2020.07.043 |
| |
| Authors: | Qian Hong Zenghui Wang Yang Yang Lu Gao Zhao Yan |
| |
| Abstract: | Diterpene ginkgolides meglumine injection (DGMI), a kind of Ginkgo biloba special extract injection, is now used for the treatment of ischemic stroke in convalescence. In the present study, we aimed to confirm whether DGMI could suppress inflammatoryresponses and apoptosis and explore the potential mechanisms underlying these effects. Cell viability and lactate dehydrogenase (LDH) release were measured by MTS and LDH assays after the cells were exposed to oxygen-glucose deprivation/reoxygenation (OGD/R). The extent of anti-apoptotic effect of DGMI was detected by flow cytometry using Annexin V-FITC/PI double staining assay kit. Pro-inflammatory cytokines, including TNF-α, IL-1β, IL-6 and IL-10, were quantified by a specific Bio-Plex ProTM Reagent Kit. Additionally, activities of TLR2/4, NF-κB p65, MAPK pathway and apoptosis-related proteins as well as cellular localization of NF-κB p65 were determined by Western blotting analysis and immunofluorescence staining, respectively. DGMI at 50 μg/mL significantly increased the cell viability and decreased the secretion of IL-1β, IL-6, IL-10 and TNF-α in OGD/R-induced BV2 microglia cells. These effects were also confirmed by LDH assay and Annexin V-FITC/PI staining. Meanwhile, DGMI not only inhibited the protein expressions of TLR2, TLR4, MyD88, p-TAK1, p-IkBα, p-IKKβ and Bak, but also decreased the cleaved caspase-3/caspase-3, Bax/Bcl-2 and cleaved PARP-1/PARP-1 ratio in OGD/R-induced BV2 microglia cells. Furthermore, OGD/R-enhanced p-JNK1/2 and p-p38 MAPK expressions and nuclear translocation of NF-κB p65 were also partially inhibited by DGMI. The present study showed that inflammatoryresponses were triggered in BV2 microglia cells activated by OGD/R, leading tothe release of pro-inflammatory cytokines and apoptosis. DGMI suppressed the inflammatory response and apoptosis by regulating the TLR/MyD88/NF-κB signaling pathways and down-regulation of p-JNK1/2 and p-p38 MAPK activation. |
| |
| Keywords: | Ginkgolides BV2 microglia cells TLR Cerebral ischemia NF-κB MAPK Inflammation |
|
| 点击此处可从《中国药学》浏览原始摘要信息 |
|
点击此处可从《中国药学》下载免费的PDF全文 |
|
